Rezolute , Inc. (NASDAQ:RZLT), a clinical-stage biopharmaceutical company, is making significant strides in the development ...

At the Envision Summit 2025 in San Juan, Puerto Rico, Deepak Sambhara, MD, gave insight into the 96-week post hoc fluid ...

Adding probiotics to antipsychotic treatment is associated with a significant decrease in schizophrenia symptoms, a new ...

The "Sinusitis Pipeline Insight Analysis Report" drug pipelines has been added to ResearchAndMarkets.com's offering.The sinusitis treatment pipeline analysis provides an overview of recent ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a biotechnology company focused on developing small molecule drugs for viral infections and liver diseases, is navigating a critical phase in its evolution.

Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...

The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, has been involved with three papers published this week in The Lancet and ...

Targeted Variable Analysis: Identify hard-to-detect combinations ... Delivering Key Benefits for Your Trials Enhanced Efficacy: Optimize key clinical endpoints with high effect-size models for ...

Virtual reality technology is linked to greater motor rehabilitation improvements in critically ill patients than traditional ...

To predict arrhythmic risk in carriers of filamin C truncating variants, a novel risk predictive model was developed based on ...

Targeted Variable Analysis: Identify hard-to-detect combinations of key ... Delivering Key Benefits for Your Trials Enhanced Efficacy: Optimize key clinical endpoints with high effect-size models for ...

This drive for improvement has seen the emergence of Sub-population Optimisation & Modelling Solutions (SOMS), a new approach to clinical trial methodology and analysis that harnesses the power of ...